Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 672.92K CAD in the quarter ending August 31, 2025, with 30.43% growth. This brings the company's revenue in the last twelve months to 2.63M, up 95.76% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.

• Revenue (ttm): 2.63M
• Revenue Growth: +95.76%
• P/S Ratio: 7.50
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 19.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	2.09M	1.06M	104.34%
Feb 29, 2024	1.02M	302.13K	42.06%
Feb 28, 2023	718.30K	-1.03M	-59.00%
Feb 28, 2022	1.75M	996.72K	131.98%
Feb 28, 2021	755.20K	653.70K	644.06%